206 related articles for article (PubMed ID: 15230667)
21. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
Gao Q; Hogezand RA; Lamers CB; Verspaget HW
Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
[TBL] [Abstract][Full Text] [Related]
22. Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease: a pilot study.
González-Lama Y; Abreu L; Vera MI; Pastrana M; Tabernero S; Revilla J; Durán JG; Escartin P
Inflamm Bowel Dis; 2005 Jan; 11(1):8-15. PubMed ID: 15674108
[TBL] [Abstract][Full Text] [Related]
23. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study.
Sands BE; Blank MA; Diamond RH; Barrett JP; Van Deventer SJ
Aliment Pharmacol Ther; 2006 Apr; 23(8):1127-36. PubMed ID: 16611273
[TBL] [Abstract][Full Text] [Related]
24. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease.
Lichtenstein GR; Yan S; Bala M; Blank M; Sands BE
Gastroenterology; 2005 Apr; 128(4):862-9. PubMed ID: 15825070
[TBL] [Abstract][Full Text] [Related]
25. Infliximab treatment and prognostic factors for response in patients with Crohn's disease.
Mendoza JL; García-Paredes J; Cruz Santamaria DM; Lana R; Ramírez Fernández E; Rodríguez Asteaga E; Díaz-Rubio M
Rev Esp Enferm Dig; 2002 May; 94(5):269-79. PubMed ID: 12474335
[TBL] [Abstract][Full Text] [Related]
26. Infliximab in fistulizing Crohn's disease.
Osterman MT; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Dec; 35(4):795-820. PubMed ID: 17129814
[TBL] [Abstract][Full Text] [Related]
27. Response to infliximab is related to disease duration in paediatric Crohn's disease.
Lionetti P; Bronzini F; Salvestrini C; Bascietto C; Canani RB; Dé Angelis GL; Guariso G; Martelossi S; Papadatou B; Barabino A
Aliment Pharmacol Ther; 2003 Aug; 18(4):425-31. PubMed ID: 12940928
[TBL] [Abstract][Full Text] [Related]
28. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
Ochsenkühn T; Göke B; Sackmann M
Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
[TBL] [Abstract][Full Text] [Related]
29. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.
Sandborn WJ; Hanauer SB
Am J Gastroenterol; 2002 Dec; 97(12):2962-72. PubMed ID: 12492177
[TBL] [Abstract][Full Text] [Related]
30. Fistula response to methotrexate in Crohn's disease: a case series.
Mahadevan U; Marion JF; Present DH
Aliment Pharmacol Ther; 2003 Nov; 18(10):1003-8. PubMed ID: 14616166
[TBL] [Abstract][Full Text] [Related]
31. Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: results from a prospective study.
Roumeguère P; Bouchard D; Pigot F; Castinel A; Juguet F; Gaye D; Capdepont M; Zerbib F; Laharie D
Inflamm Bowel Dis; 2011 Jan; 17(1):69-76. PubMed ID: 20623697
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.
Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P
Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051
[TBL] [Abstract][Full Text] [Related]
33. Long-term oral tacrolimus in refractory to infliximab fistulizing Crohn's disease: comments from Spanish experience.
González Lama Y; Abreu LE; Vera MI; de la Revilla J; Fernandez-Puga N; Escartin P
Gastroenterology; 2004 Mar; 126(3):942-3; author reply 943. PubMed ID: 14988864
[No Abstract] [Full Text] [Related]
34. Infliximab for the treatment of fistulas in patients with Crohn's disease.
Present DH; Rutgeerts P; Targan S; Hanauer SB; Mayer L; van Hogezand RA; Podolsky DK; Sands BE; Braakman T; DeWoody KL; Schaible TF; van Deventer SJ
N Engl J Med; 1999 May; 340(18):1398-405. PubMed ID: 10228190
[TBL] [Abstract][Full Text] [Related]
35. Complete resolution of enterocolic fistulas with infliximab.
Nunes J; Santos PM; Tavares L
BioDrugs; 2010 Dec; 24 Suppl 1():28-30. PubMed ID: 21175233
[TBL] [Abstract][Full Text] [Related]
36. Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study.
Sands BE; Blank MA; Patel K; van Deventer SJ;
Clin Gastroenterol Hepatol; 2004 Oct; 2(10):912-20. PubMed ID: 15476155
[TBL] [Abstract][Full Text] [Related]
37. Clinical use of Infliximab in Crohn's disease: the Edinburgh experience.
Arnott ID; McDonald D; Williams A; Ghosh S
Aliment Pharmacol Ther; 2001 Oct; 15(10):1639-46. PubMed ID: 11564005
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcome of Crohn's disease treated with infliximab.
Arslan S; Kav T; Besisik F; Kaymakoglu S; Pinarbasi B; Tözün N; Hamzaoglu HO; Duman D; Ulker A; Parlak E; Palabiyikoglu M; Dökmeci A
Hepatogastroenterology; 2003; 50(52):952-6. PubMed ID: 12845957
[TBL] [Abstract][Full Text] [Related]
39. Infliximab therapy improves the bone metabolism in fistulizing Crohn's disease.
Miheller P; Muzes G; Zagoni T; Toth M; Racz K; Tulassay Z
Dig Dis; 2006; 24(1-2):201-6. PubMed ID: 16699279
[TBL] [Abstract][Full Text] [Related]
40. Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's disease.
Rasul I; Wilson SR; MacRae H; Irwin S; Greenberg GR
Am J Gastroenterol; 2004 Jan; 99(1):82-8. PubMed ID: 14687146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
